Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$0.42 - $0.93 $389,744 - $863,005
927,963 Added 41.2%
3,180,059 $2.51 Million
Q2 2023

Aug 14, 2023

BUY
$1.19 - $1.79 $559,910 - $842,218
470,513 Added 26.41%
2,252,096 $3.09 Million
Q1 2023

May 12, 2023

BUY
$1.48 - $2.74 $2.64 Million - $4.88 Million
1,781,547 Added 4948741.5%
1,781,583 $3.22 Million
Q4 2022

Feb 10, 2023

BUY
$0.46 - $8.9 $16 - $320
36 New
36 $0

Others Institutions Holding JSPR

# of Institutions
1
Shares Held
5.63M
Call Options Held
0
Put Options Held
0

About Jasper Therapeutics, Inc.


  • Ticker JSPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,073,300
  • Market Cap $843M
  • Description
  • Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engineering to allow expanded use of stem cell transplantation and ex vivo gene therapy, a techniqu...
More about JSPR
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.